The Traderszone Network

What: Ionis Pharmaceuticals (NASDAQ: IONS) is down nearly 40% at 1:15 p.m. EDT after the company announced that its partner, GlaxoSmithKline (NYSE: GSK), doesn’t plan to initiate a phase 3 for IONIS-TTRRx in patients with transthyretin (TTR)-related amyloid cardiomyopathy.

Yet.

read more

What: Ionis Pharmaceuticals (NASDAQ: IONS) is down nearly 40% at 1:15 p.m. EDT after the company announced that its partner, GlaxoSmithKline (NYSE: GSK), doesn’t plan to initiate a phase 3 for IONIS-TTRRx in patients with transthyretin (TTR)-related amyloid cardiomyopathy.

Yet.

read more

Donald Trump will head to the heart of America’s oil and gas boom on Thursday to unveil details of his policies on energy and the environment. As NYTimes reports, speaking at an oil industry conference in Bismarck, N.D., Mr.

read more

Donald Trump will head to the heart of America’s oil and gas boom on Thursday to unveil details of his policies on energy and the environment. As NYTimes reports, speaking at an oil industry conference in Bismarck, N.D., Mr.

read more

The main reason stocks in the steel sector are on fire today is because overnight the Commerce Department escalated its trade war with China when it implemented the latest clampdown on a glut of steel imports, when it announced that corrosion-resistant steel from China will face final U.S. anti-dumping and anti-subsidy duties of up to 450%. The final U.S. anti-dumping duties on the Chinese products replace preliminary ones of 256% issued in December 2015.

read more

Bonds up, Stocks up… will Yellen spoil the party tomorrow?

Bonds are not buying the bullish Fed rate hike meme…

and JPY is strengthening again…

read more

Charging a Ford Focus Electric. Image source: Ford. 

Tesla Motors (NASDAQ: TSLA) has taken the world by storm with its push into high-powered electric vehicles and has built a $31 billion business in the process. Nearly 400,000 pre-orders for the Model 3 make the company’s standing in the industry undeniable. 

read more